FDA Looks Ahead To Complex Product-Specific Guidances

Exploring The US FDA's Upcoming Complex Generic Product-Specific Guidance Lists

 
• By Derrick Gingery

The agency offers a glimpse of its regulatory agenda, although several have been carried over through multiple list updates.

Guidance
The US FDA issued more revised than new product-specific guidances for generic products in fiscal year 2019, unlike past fiscal years • Source: Shutterstock

Complex generic drug sponsors now can track the US Food and Drug Administration's plans for new and revised product-specific guidances and potentially avoid development or application assessment setbacks.

However, like the agency’s other guidance agendas, in many cases product-specific guidances (PSGs) have remained listed as upcoming or due...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Generics

More from Products